Skip to main content
SpringerLink
Log in

Radiothérapie de clôture

  • Chapter
Les cancers ovariens

Part of the book series: Abord clinique ((ONCOLPRAT))

  • 326 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Elit L, Chambers A, Fyles A et al. (2004) Systematic review of adjuvant care for women with Stage I ovarian carcinoma. Cancer 101(9): 1926–35

    Article  PubMed  Google Scholar 

  2. Hreshchyshyn MM, Park RC, Blessing JA et al. (1980) The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 138(2): 139–45

    CAS  PubMed  Google Scholar 

  3. Dembo AJ, Van Dyk J, Japp B et al. (1979) Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys 5(11–12): 1933–42

    CAS  PubMed  Google Scholar 

  4. Chiara S, Conte P, Franzone P et al. (1994) High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 17(1): 72–6

    CAS  PubMed  Google Scholar 

  5. Gronroos M, Nieminen U, Kauppila A et al. (1984) A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. Eur J Obstet Gynecol Reprod Biol 17(1): 33–42

    Article  CAS  PubMed  Google Scholar 

  6. Fuller DB, Sause WT, Plenk HP et al. (1987) Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. J Clin Oncol 5(6): 897–905

    CAS  PubMed  Google Scholar 

  7. MacGibbon A, Bucci J, MacLeod C et al. (1999) Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma. Gynecol Oncol 75(1): 62–7

    Article  CAS  PubMed  Google Scholar 

  8. Debby A, Levy T, Hayat H et al. (2004) Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis. Int J Gynecol Cancer 14(5): 794–8

    Article  CAS  PubMed  Google Scholar 

  9. Martinez A, Schray MF, Howes AE et al. (1985) Postoperative radiation therapy for epithelial ovarian cancer: the curative role based on a 24-year experience. J Clin Oncol 3(7): 901–11

    CAS  Google Scholar 

  10. Lambert HE, Rustin GJ, Gregory WM et al. (1993) A randomized trial comparing singleagent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study. J Clin Oncol 11(3): 440–8

    CAS  PubMed  Google Scholar 

  11. Sorbe B (2003) Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy. Int J Gynecol Cancer 13Suppl 2: 192–5

    PubMed  Google Scholar 

  12. Bruzzone M, Repetto L, Chiara S et al. (1990) Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecol Oncol 38(3): 392–5

    Article  CAS  PubMed  Google Scholar 

  13. Berlie J, Delouche G, Weber B et al. (1987) Four year survival of ovarian serous carcinoma (stage IIC, III, IV FIGO) treated by two four-drug chemotherapy: AVEC (ADR, VM26, CTX, CDDP) versus CHAP (CTX, HMM, ADR, CDDP) and for responders after the second-look, a maintenance treatment: total abdominal radiotherapy vs chemotherapy. A double randomized trial of the gynecological group of the french centers Berlie1987. Pro 4th European Conference on Clinical Oncology and Cancer Nursing (ECCO4), 784. Ref Type: Abstract

    Google Scholar 

  14. Lawton F, Luesley D, Blackledge G et al. (1990) A randomized trial comparing whole abdominal radiotherapy with chemotherapy following cisplatinum cytoreduction in epithelial ovarian cancer. West Midlands Ovarian Cancer Group Trial II. Clin Oncol (R Coll Radiol) 2(1): 4–9

    CAS  Google Scholar 

  15. Pickel H, Lahousen M, Petru E et al. (1999) Consolidation radiotherapy after carboplatinbased chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 72(2): 215–9

    Article  CAS  PubMed  Google Scholar 

  16. Dembo AJ (1983) Radiation therapy in the management of ovarian cancer. Clin Obstet Gynaecol 10, 261–78

    CAS  PubMed  Google Scholar 

  17. Delclos L, Smith J (1973) Tumors of the ovary. Text-book of radiotherapy 690–702

    Google Scholar 

  18. Fletcher G, Shukovsky L (1975) The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol 56: 383–400

    CAS  PubMed  Google Scholar 

  19. Eifel PJ, Gershenson DM, Delclos L et al. (1991) Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma. Int J Radiat Oncol Biol Phys 21(4): 1013–8

    CAS  PubMed  Google Scholar 

  20. Randall ME, Barrett RJ, Spirtos NM et al. (1996) Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 34(1): 139–47

    Article  CAS  PubMed  Google Scholar 

  21. Young RC, Walton LA, Ellenberg SS, et al. (1990) Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322(15): 1021–7

    CAS  PubMed  Google Scholar 

  22. Vergote I, De Vos L, Abeler V et al. (1992) Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer. Cancer 69: 741–9

    CAS  PubMed  Google Scholar 

  23. Klaasen D, Shelley W, Starreveld A et al. (1988) Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical trials Group Report. J Clin Oncol 6: 1254–63

    Google Scholar 

  24. Vergote I, Winderen M, De Vos L et al. (1993) Intraperitoneal radioactive phosphate in early ovarian carcinome: an analysis of complications. Cancer 71: 2250–60

    CAS  PubMed  Google Scholar 

  25. Varia M, Rosenman J, Venkatraman S et al. (1988) Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer. Cancer 61(5): 919–27

    CAS  PubMed  Google Scholar 

  26. Varia MA, Stehman FB, Bundy BN et al. (2003) Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. J Clin Oncol 21(15): 2849–55

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. L. Claude
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.-P. Sunyach
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Claude, L., Sunyach, MP. (2006). Radiothérapie de clôture. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_22

Download citation

  • DOI: https://doi.org/10.1007/2-287-30921-7_22

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25168-9

  • Online ISBN: 978-2-287-30921-2

Publish with us

Policies and ethics

Search

Navigation